Trial intelligence / Profile preview

Sugammadex vs Neostigmine for Postoperative Respiratory Outcomes

NCT02361060Phase 4Completed

Start
Feb 2015
Primary completion
Jul 2016
Modality
Biodegradable Polymers, Small Molecules
Countries
1
01

Overview

A Phase 4 trial of Sugammadex in postoperative pulmonary complications (PPC). Started Feb 2015; status: completed.

02

Drugs

Sugammadex
03

Conditions

postoperative pulmonary complications (PPC)

Beyond the preview

Go deeper on NCT02361060.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02361060.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call